Evotec, PsychoGenics Partner on CNS Drug Discovery Services | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Evotec today said that it has teamed up with PsychoGenics to offer pharmaceutical and biotech companies CNS drug discovery services.

The firms will offer clients access to their complementary drug discovery platforms for identifying and developing new therapeutics for central nervous system disorders. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.